OAM
REGN icon

OP Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

OP Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.29M Sell
11,685
-2,454
-17% -$1.67M 0.08% 195
2026
Q1 		$10.9M Buy
14,139
+2,424
+21% +$1.86M 0.09% 132
2025
Q4 		$9.04M Buy
11,715
+59
+0.5% +$40.1K 0.11% 145
2025
Q3 		$6.55M Buy
11,656
+311
+3% +$176K 0.09% 181
2025
Q2 		$5.96M Sell
11,345
-354
-3% -$198K 0.09% 183
2025
Q1 		$7.42M Buy
+11,699
New +$8.05M 0.13% 139

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

OP Asset Management's REGN Position: Q2 2026 in Review

OP Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 17% in Q2 2026, selling an estimated $1.67M and leaving 11,685 shares worth $7.29M. The position accounts for 0.08% of the portfolio, ranked #195.

OP Asset Management first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $10.9M in Q1 2026. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • OP Asset Management held 11,685 shares of Regeneron Pharmaceuticals worth $7.29M as of Q2 2026.
  • OP Asset Management sold 2,454 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.67M.
  • Regeneron Pharmaceuticals made up 0.08% of OP Asset Management's portfolio in Q2 2026, its #195 holding.
  • OP Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • OP Asset Management's Regeneron Pharmaceuticals position peaked at $10.9M in Q1 2026.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.